Other Name(s): None
Assay:Inhibition of human recombinant HGF-mediated cMet phosphorylation in human PC3 cells
Type:IC50
SMILES:COc1cc2nccc(Oc3ccc(-c4cnc(Cc5ccccc5)n(C)c4=O)cc3F)c2cc1OC
Value:=313nM
Source:Homo sapiens
Assay:Inhibition of human recombinant HGF-mediated cMet phosphorylation in human PC3 cells
Type:IC50
SMILES:COc1cc2c(Oc3ccc(-c4cnc(Nc5ccc(F)cc5)n(C)c4=O)nc3)ccnc2cc1OCCCN1CCOCC1
Value:=69nM
Source:Homo sapiens
Assay:Inhibition of human recombinant HGF-mediated cMet phosphorylation in human PC3 cells
Type:IC50
SMILES:COc1cc2c(Oc3ccc(-c4cnc(Nc5ccc(F)cc5)n(C)c4=O)cc3F)ccnc2cc1OCCCN1CCOCC1
Value:=64nM
Source:Homo sapiens
Assay:Inhibition of human recombinant HGF-mediated cMet phosphorylation in human PC3 cells
Type:IC50
SMILES:COc1cc2c(Oc3ccc(-c4cnc(Cc5ccc(F)cc5)n(C)c4=O)cc3F)ccnc2cc1OCCCN1CCOCC1
Value:=161nM
Source:Homo sapiens
Assay:Inhibition of human recombinant HGF-mediated cMet phosphorylation in mouse CT26 cells
Type:IC50
SMILES:COc1cc2nccc(Oc3ccc(-c4cnc(Cc5ccccc5)n(C)c4=O)cc3F)c2cc1OC
Value:=368nM
Source:Homo sapiens
Assay:Inhibition of human recombinant HGF-mediated cMet phosphorylation in mouse CT26 cells
Type:IC50
SMILES:COc1cc2c(Oc3ccc(-c4cnc(Nc5ccc(F)cc5)n(C)c4=O)nc3)ccnc2cc1OCCCN1CCOCC1
Value:=59nM
Source:Homo sapiens
Assay:Inhibition of human recombinant HGF-mediated cMet phosphorylation in mouse CT26 cells
Type:IC50
SMILES:COc1cc2c(Oc3ccc(-c4cnc(Nc5ccc(F)cc5)n(C)c4=O)cc3F)ccnc2cc1OCCCN1CCOCC1
Value:=82nM
Source:Homo sapiens
Assay:Inhibition of human recombinant HGF-mediated cMet phosphorylation in mouse CT26 cells
Type:IC50
SMILES:COc1cc2c(Oc3ccc(-c4cnc(Cc5ccc(F)cc5)n(C)c4=O)cc3F)ccnc2cc1OCCCN1CCOCC1
Value:=196nM
Source:Homo sapiens
Assay:Binding affinity to immobilized HGF (unknown origin) by surface plasmon resonance analysis
Type:Kd
SMILES:Nc1c(S(=O)(=O)[O-])cc(Nc2ccc(-c3ccc(Nc4cc(S(=O)(=O)[O-])c(N)c5c4C(=O)c4ccccc4C5=O)cc3)cc2)c2c1C(=O)c1ccccc1C2=O.[Na+].[Na+]
Value:=1950nM
Source:Homo sapiens
Assay:Inhibitory concentration of the compound against HGF-stimulated c-Met signalingCactivation using ELISA method
Type:IC50
SMILES:CN1C=C(C=N1)C1=CN2C(C=C1)=NC=C2S(=O)(=O)N1N=CC2=C1C=C(C=N2)C1=CN(C)N=C1
Value:=8.8nM
Source:
Assay:In vitro inhibitory concentration of the compound against HGF receptor
Type:IC50
SMILES:COC1=C(OCCCN2CCOCC2)C=C2N=CC=C(OC3=CC=C(NC(=O)C4(CC4)C(=O)NC4=CC=C(F)C=C4)C=C3F)C2=C1
Value:=3nM
Source:
Assay:Inhibitory concentration of the compound against HGF expressing A-431 cell line
Type:IC50
SMILES:[H]O[C@@H]1[C@@H](COS(=O)(=O)C2=CC(=CC=C2)C(F)(F)F)O[C@H](OC3=CC=C(I)C=C3)[C@H](OC(=O)CCC4=CC=CC=C4)[C@H]1OCC=C
Value:=2uM
Source:
Assay:Binding affinity (KD) of compound towards activation of pro Hepatocyte Growth Factor beta binding to met Receptor
Type:Kd
SMILES:CC[C@H](C)[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)NCC(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C(C)C)C(O)=O
Value:=34uM
Source:
Assay:Binding affinity (KD) of compound towards activation of pro Hepatocyte Growth Factor beta binding to met Receptor
Type:Kd
SMILES:CC[C@H](C)[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)NCC(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C(C)C)C(O)=O
Value:=85uM
Source:
Assay:Binding affinity (KD) of compound towards activation of pro Hepatocyte Growth Factor beta binding to met Receptor
Type:Kd
SMILES:CC[C@H](C)[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)NCC(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N1CC(O)C[C@H]1C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C(C)C)C(O)=O
Value:=14uM
Source:
Assay:Binding affinity (KD) of compound towards activation of pro Hepatocyte Growth Factor beta binding to met Receptor
Type:Kd
SMILES:CC[C@H](C)[C@H](N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)NCC(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N1CC(O)C[C@H]1C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C(C)C)C(O)=O
Value:=5uM
Source:
Assay:Binding affinity (KD) of compound towards activation of pro Hepatocyte Growth Factor beta binding to met Receptor
Type:Kd
SMILES:CC[C@H](C)[C@H](N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC1=CN=CN1)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C)C(O)=O
Value:=6uM
Source:
Assay:Binding affinity (KD) of compound towards activation of pro Hepatocyte Growth Factor beta binding to met Receptor
Type:Kd
SMILES:CC[C@H](C)[C@H](N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)NCC(=O)N[C@@H](CS)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CS)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O
Value:=0.3uM
Source:
Assay:Binding affinity (KD) of compound towards activation of pro Hepatocyte Growth Factor beta binding to met Receptor
Type:Kd
SMILES:CC[C@H](C)[C@H](N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)NCC(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O
Value:=59uM
Source:
Assay:Binding affinity (KD) of compound towards activation of pro Hepatocyte Growth Factor beta binding to met Receptor
Type:Kd
SMILES:CC[C@H](C)[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@H](CC(O)=O)C(=O)NCC(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C(C)C)C(O)=O
Value:=21uM
Source:

Note: If you'd like to learn how our AI-powered BDE-Chem can help design therapeutic molecules against the HGF target, that break through the existing patents, at a cost 90% lower than traditional approaches, please feel free to contact us at BD@silexon.ai

Molecules for More Common Targets

ABCB1 | ABCG2 | ACE2 | AHR | AKT1 | ALK | AR | ATM | BAX | BCL2 | BCL2L1 | BRAF | BRCA1 | CASP3 | CASP9 | CCL5 | CCND1 | CD274 | CD4 | CDKN1A | CXCL8 | CXCR4 | DNMT1 | EGF | EGFR | EP300 | ERBB2 | ESR1 | EZH2 | FN1 | FOXO3 | HDAC9 | HGF | HMGB1 | HSP90AA1 | HSPA5 | IDO1 | IGF1 | IGF1R | IL17A | IL6 | INS | JUN | KRAS | MAPK1 | MAPK14 | MAPK3 | MAPK8 | MAPT | MCL1 | MMP9 | MTOR | MYC | NFE2L2 | NLRP3 | NOTCH1 | PARP1 | PCNA | PDCD1 | PLK1 | PRKAA1 | PRKAA2 | PTEN | PTGS2 | PTK2 | RELA | SIRT1 | SRC | STAT1 | STAT3 | STAT5A | TERT | TLR4 | TNF | TP53 | TXN | VEGFA | YAP1